Category: Drug Development
Drug Development market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Early Toxicity Testing
The 2025-2030 World Outlook for Early Toxicity Testing This study covers the world outlook for early toxicity testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs
The 2025-2030 World Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs This study covers the world outlook for anti-viral nucleotide polymerase inhibitor drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings ... Read More
-
The 2025-2030 World Outlook for Smart Pill Capsule Endoscopy Technologies
The 2025-2030 World Outlook for Smart Pill Capsule Endoscopy Technologies This study covers the world outlook for smart pill capsule endoscopy technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for ... Read More
-
The 2025-2030 World Outlook for Breakthrough Therapy Designation
The 2025-2030 World Outlook for Breakthrough Therapy Designation This study covers the world outlook for breakthrough therapy designation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2025-2030 World Outlook for Immunotherapy Drugs
The 2025-2030 World Outlook for Immunotherapy Drugs This study covers the world outlook for immunotherapy drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Pandemic Infectious Disease Products
The 2025-2030 World Outlook for Pandemic Infectious Disease Products This study covers the world outlook for pandemic infectious disease products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the countr ... Read More
-
The 2025-2030 World Outlook for Marine Biotechnologies
The 2025-2030 World Outlook for Marine Biotechnologies This study covers the world outlook for marine biotechnologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Technologies
The 2025-2030 World Outlook for Drug Discovery Technologies This study covers the world outlook for drug discovery technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Fragment Screening Drug Discovery
The 2025-2030 World Outlook for Fragment Screening Drug Discovery This study covers the world outlook for fragment screening drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Cancer Immunotherapies
The 2025-2030 World Outlook for Cancer Immunotherapies This study covers the world outlook for cancer immunotherapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Lymphoma Treatments
The 2025-2030 World Outlook for Lymphoma Treatments This study covers the world outlook for lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2025-2030 World Outlook for Influenza
The 2025-2030 World Outlook for Influenza This study covers the world outlook for influenza across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the perce ... Read More
-
The 2025-2030 World Outlook for Organ-on-a-Chip
The 2025-2030 World Outlook for Organ-on-a-Chip This study covers the world outlook for organ-on-a-chip across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Drug Designing Tools
The 2025-2030 World Outlook for Drug Designing Tools This study covers the world outlook for drug designing tools across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Drug Developments
The 2025-2030 World Outlook for Drug Developments This study covers the world outlook for drug developments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Outsourcing
The 2025-2030 World Outlook for Drug Discovery Outsourcing This study covers the world outlook for drug discovery outsourcing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Biosimulation Technology Software
The 2025-2030 World Outlook for Biosimulation Technology Software This study covers the world outlook for biosimulation technology software across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Rare Disease Treatments
The 2025-2030 World Outlook for Rare Disease Treatments This study covers the world outlook for rare disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Live Cell Encapsulation
The 2025-2030 World Outlook for Live Cell Encapsulation This study covers the world outlook for live cell encapsulation across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
-
The 2025-2030 World Outlook for Drug Discovery Informatics
The 2025-2030 World Outlook for Drug Discovery Informatics This study covers the world outlook for drug discovery informatics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Fragment-Based Drug Discovery
The 2025-2030 World Outlook for Fragment-Based Drug Discovery This study covers the world outlook for fragment-based drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi) This study covers the world outlook for drug discovery and development RNA interference (RNAi) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma
The 2025-2030 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma This study covers the world outlook for premetrexed and combinations for malignant mesothelioma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indu ... Read More
-
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments
The 2025-2030 World Outlook for Progressive Multifocal Leukoencephalopathy Treatments This study covers the world outlook for progressive multifocal leukoencephalopathy treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry ... Read More
-
The 2025-2030 World Outlook for Kaposi Sarcomas
The 2025-2030 World Outlook for Kaposi Sarcomas This study covers the world outlook for Kaposi sarcomas across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
Research Assistance
